Which laboratory/clinical findings guide the decision to initiate exchange transfusion for severe hyperbilirubinemia?

• A. Bilirubin level relative to age in hours and gestational age; signs of acute bilirubin encephalopathy; per hospital thresholds.
• B. Total bilirubin level alone guides the decision.
• C. Direct bilirubin measurement alone determines need for exchange.
• D. Jaundice observed within the first 24 hours is sufficient to trigger exchange transfusion.

Answer: (B)

The key idea is that deciding to perform exchange transfusion is based on where the bilirubin level falls for the infant’s specific age in hours and gestational age, combined with signs of bilirubin-related brain injury, rather than on a single number alone. In practice, clinicians use age-adjusted thresholds (often depicted on nomograms like the Bhutani curve) to determine when a bilirubin level becomes high enough to warrant exchange, and they also look for clinical signs of acute bilirubin encephalopathy. If the level crosses the hospital’s exchange threshold for that exact age and maturity, or if there are concerning neurologic signs, exchange transfusion is considered to prevent bilirubin-induced neurologic damage. Direct bilirubin measurement helps identify conjugated hyperbilirubinemia and guide further work-up, but it does not alone determine the need for exchange. Jaundice within the first day prompts urgent assessment, but by itself it does not mandate exchange without considering the age-specific risk thresholds and clinical status.